OKYO Pharma logo NEW.JPG
OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces filing of a patent application covering the use of Chemerin and associated analogues to treat “cytokine storm” associated with COVID-19 and ARDS
19 janv. 2021 02h00 HE | OKYO Pharma LTD
LONDON and BOSTON, Jan. 19, 2021 (GLOBE NEWSWIRE) -- OKYO (LSE: OKYO; OTCQB: EMMLF), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat...
OKYO Pharma logo NEW.JPG
OKYO Pharma Limited ("OKYO" or the "Company") - Result of the Annual General Meeting
25 sept. 2020 07h00 HE | OKYO Pharma LTD
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM...
OKYO Pharma logo NEW.JPG
Notice of Annual General Meeting
09 sept. 2020 02h00 HE | OKYO Pharma LTD
LONDON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat...
OKYO Pharma logo NEW.JPG
OKYO Pharma Limited ("OKYO" or the "Company") - Appointment of Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board
19 août 2020 02h00 HE | OKYO Pharma LTD
LONDON, Aug. 19, 2020 (GLOBE NEWSWIRE) -- OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and...
OKYO Pharma logo NEW.JPG
OKYO Pharma Limited ("OKYO" or the "Company") - Issue of additional convertible loan notes to raise £1,437,104 and intention to seek dual listing on NASDAQ
18 août 2020 02h00 HE | OKYO Pharma LTD
LONDON, Aug. 18, 2020 (GLOBE NEWSWIRE) -- OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and...
OKYO Pharma logo NEW.JPG
Dr James Khodabakhsh MD named Chairman of the Scientific Advisory Board at OKYO Pharma Ltd
07 août 2020 02h00 HE | OKYO Pharma LTD
LONDON, Aug. 07, 2020 (GLOBE NEWSWIRE) -- OKYO (LSE:OKYO), the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye...
OKYO Pharma logo NEW.JPG
OKYO Pharma Limited ("OKYO" or the "Company") - Company Presentation
03 août 2020 02h00 HE | OKYO Pharma LTD
LONDON, Aug. 03, 2020 (GLOBE NEWSWIRE) -- OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and...
OKYO Pharma logo NEW.JPG
OKYO Pharma Limited - Upcoming Presentation
31 juil. 2020 11h30 HE | OKYO Pharma LTD
LONDON, July 31, 2020 (GLOBE NEWSWIRE) -- OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and...
OKYO Pharma logo NEW.JPG
OKYO Pharma Limited ("OKYO" or the "Company") - Issue of convertible loan notes to raise £3,500,000
28 juil. 2020 06h14 HE | OKYO Pharma LTD
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY...